UCR Health multiple sclerosis experts and university researchers are actively seeking new therapeutic approaches to treatment of this debilitating disease. Multiple sclerosis research studies at University of California, Riverside include:
Clinicians’ Online Neurology Network Empowering Communities through Telemedicine – Multiple Sclerosis (CONNECT-MS)
This research project, funded by a grant from Genentech, is developing and testing a home-based telemedicine outreach program for people living with multiple sclerosis in medically underserved areas of southern California.
For further information about the CONNECT-MS project, please contact Elizabeth Morrison-Banks, MD, MSEd
Research on Remyelination and Neuroprotection in Multiple Sclerosis
The Tiwari-Woodruff laboratory on UCR’s main campus investigates mechanisms of demyelination-induced neurodegeneration and therapeutic neuroprotection using rodent models of MS and human postmortem tissue from brain banks.
Some of the key demyelinating symptoms that Seema Tiwari-Woodruff, PhD
and colleagues are investigating include optic neuritis, learning and memory problems, and seizure activity in MS. Collaborating with fellow researchers at UCLA, UC-Irvine and pharmaceutical companies including Teva and Novartis, the laboratory studies the mechanisms of action of approved and potential MS treatments and how effective these treatments are for neuroprotection and remyelination of central nervous system injury from MS and other neurodegenerative diseases.
For further information about these studies, please contact Seema Tiwari-Woodruff, PhD at 951.827.7819